血栓性微血管病变中的致病性细胞因子:分子洞察力和治疗点
1Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe. emmanuelobeagu@yahoo.com.
Molecular medicine (Cambridge, Mass.)
|October 24, 2025
概括
支持炎症的细胞因子如TNF-α,IL-6和IL-1β在血栓性微血管病变 (TMAs) 中驱动内皮损伤. 这种细胞因子介导的炎症是多种TMA亚型的常见途径,导致微血管血栓形成.
科学领域:
- 血管生物学 血管生物学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 血栓性微血管病变 (TMAs) 包含多种疾病,其特征是内皮损伤,微血管血栓症,血栓细胞减小和血液溶解性贫血.
- 尽管有各种各样的触发因素 (感染,自身免疫性疾病,遗传因素),但共同点是血管内皮损伤.
研究的目的:
- 阐明促炎性细胞因子在TMAs病理生理学的作用.
- 为了识别不同TMA亚型的共享炎症机制.
主要方法:
- 对了解TMA病原学的最新进展进行审查.
- 分析特定细胞因子 (TNF-α,IL-6,IL-1β) 在内皮功能障碍中的作用.
主要成果:
- 亲炎性细胞因子在TMA中关键调解内皮功能障碍.
- 细胞因子促进内皮激活,通透性,白细胞粘附和前凝活动,有助于微血栓的形成.
- 细胞因子介导的炎症是与Siga毒素相关的HUS,非典型的HUS,TTP和二次TMAs的共同特征.
结论:
- 由促炎性细胞因子驱动的内皮损伤是TMA中统一的病理生理机制.
- 向细胞因子介导炎症可能为各种TMA亚型提供治疗策略.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


